SCN9A and paroxysmal extreme pain disorder: Gain-of function mutations in Nav1.7 and 1.9 result in the inherited pain syndromes erythromelalgia [6], paroxysmal extreme pain disorder [66], autosomal-dominant episodic pain [68], and small-fibre neuropathies [6].